FHIR Implementation Guide for NJSAMS
1.0.0 - release
1.0.0 - release
NJSAMS - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/SedativeHypnoticAnxiolyticDisordersQuestionnaire | Version: 1.0.0 | |||
| Draft as of 2022-08-31 | Computable Name: | |||
Criteria for Sedative Hypnotic Anxiolytic Use Disorder
Generated Narrative: Questionnaire SedativeHypnoticAnxiolyticDisordersQuestionnaire
| LinkID | Text | Cardinality | Type | Description & Constraints |
|---|---|---|---|---|
  | Criteria for Sedative Hypnotic Anxiolytic Use Disorder | Questionnaire | https://fhir.njsams.rutgers.edu/NJSAMS-fhir/Questionnaire/SedativeHypnoticAnxiolyticDisordersQuestionnaire#1.0.0 | |
  SedaDisSymptoms | null | 0..1 | group | |
  SedaDisSymptoms.501 | 501. Sedatives, hypnotics, or anxiolytics are often taken in larger amounts or over a longer period than was intended. | 0..1 | boolean | |
| SedaDisSymptoms.502 | 502. There is a persistent desire or unsuccessful efforts to cut down or control sedative, hypnotic, or anxiolytic use. | 0..1 | boolean | |
| SedaDisSymptoms.503 | 503. A great deal of time is spent in activities necessary to obtain the sedative, hypnotic, or anxiolytic, use the sedative, hypnotic, or anxiolytic, or recover from its effects. | 0..1 | boolean | |
| SedaDisSymptoms.504 | 504. Craving, or a strong desire or urge to use the sedative, hypnotic, or anxiolytic. | 0..1 | boolean | |
| SedaDisSymptoms.505 | 505. Recurrent sedative, hypnotic, or anxiolytic use resulting in a failure to fulfill major role obligations at work, school, or home. | 0..1 | boolean | |
| SedaDisSymptoms.506 | 506. Continued sedative, hypnotic, or anxiolytic use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of sedatives, hypnotics, or anxiolytics [e.g. arguments with a spouse about consequences of intoxication; physical fights]. | 0..1 | boolean | |
| SedaDisSymptoms.507 | 507. Important social, occupational, or recreational activities are given up or reduced because of sedative, hypnotic, or anxiolytic use. | 0..1 | boolean | |
| SedaDisSymptoms.508 | 508. Recurrent sedative, hypnotic, or anxiolytic use in situations in which it is physically hazardous. | 0..1 | boolean | |
| SedaDisSymptoms.509 | 509. Sedative, hypnotic, or anxiolytic use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the sedative, hypnotic, or anxiolytic. | 0..1 | boolean | |
| Tolerance | Tolerance, as defined by either of the following: | 0..1 | group | |
| SedaDisSymptoms.Tolerance.511 | 511. a. A need for markedly increased amounts of alcohol to achieve intoxication or desired effect. [Not selectable] | 0..1 | boolean | |
 SedaDisSymptoms.Tolerance.512 | 512. b. A markedly diminished effect with continued use of the same amount of the sedative, hypnotic, or anxiolytic. | 0..1 | boolean | |
| Withdrawal | Withdrawal, as manifested by either of the following: | 0..1 | group | |
 SedaDisSymptoms.Withdrawal.514 | 514. a. The characteristic withdrawal syndrome for sedatives, hypnotics, or anxiolytics[refer to Criteria A and B of the criteria set for sedative, hypnotic, or anxiolytics withdrawal, pp.265-266] | 0..1 | boolean | |
| SedaDisSymptoms.Withdrawal.515 | 515. b. Sedatives, hypnotics, or anxiolytics [or a closely related substance, such as alcohol] are taken to relieve or avoid withdrawal symptoms | 0..1 | boolean | |
| SedaIntoxSymptoms | null | 0..1 | group | |
| SedaIntoxSymptoms.525 | 525. Recent use of a sedative, hypnotic, or anxiolytic | 0..1 | boolean | |
| SedaIntoxSymptoms.526 | 526. Clinically significant maladaptive behavioral or psychological changes[e.q., inapporpriate sexual or aggressive behaviour, mood lability, impaired judgement] that developed during, or shortly after, sedative, hypnotic, or anxiolytic use. | 0..1 | boolean | |
| SignsOrSymptoms | C. One [or more] of the following signs or symptoms developing during, or shortly after,sedative, hypnotic, or anxiolytic use: | 0..1 | group | |
| SedaIntoxSymptoms.SignsOrSymptoms.528 | 528. Slurred speech | 0..1 | boolean | |
| SedaIntoxSymptoms.SignsOrSymptoms.529 | 529. Incoordination | 0..1 | boolean | |
| SedaIntoxSymptoms.SignsOrSymptoms.530 | 530. Unsteady gait | 0..1 | boolean | |
| SedaIntoxSymptoms.SignsOrSymptoms.531 | 531. Nystagmus | 0..1 | boolean | |
| SedaIntoxSymptoms.SignsOrSymptoms.532 | 532. Impairment in cognition [e.g., attention, memory] | 0..1 | boolean | |
| SedaIntoxSymptoms.SignsOrSymptoms.533 | 533. Stupor or coma | 0..1 | boolean | |
| SedaIntoxSymptoms.534 | 534. D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance. | 0..1 | boolean | |
| SedaWithdrawSymptoms | null | 0..1 | group | |
| SedaWithdrawSymptoms.536 | 536. A. Cessation of [or reduction in] sedative, hypnotic, or anxiolytic use that has been prolonged | 0..1 | boolean | |
| SideEffects | B. Two [or more] of the following, developing within several hours to a few days after the cessation of [or reduction in] sedative, hypnotic, or anxiolytic use described in Criteria A: | 0..1 | group | |
| SedaWithdrawSymptoms.SideEffects.538 | 538. Autonomic hyperactivity [e.g., sweating or pulse rate greater than 100 bpm] | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.539 | 539. Hand tremor | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.540 | 540. Insomnia | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.541 | 541. Nausea or vomiting | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.542 | 542. Transient visual, tactile, or auditory hallucinations or illusions | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.543 | 543. Psychomotor agitation | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.544 | 544. Anxiety | 0..1 | boolean | |
| SedaWithdrawSymptoms.SideEffects.545 | 545. Grand mal seizures | 0..1 | boolean | |
| SedaWithdrawSymptoms.546 | 546. C. The signs or symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. | 0..1 | boolean | |
| SedaWithdrawSymptoms.547 | 547. D. The signs or symptoms are not attributable to another medical condition and are not better explained by another mental disorder, including intoxication or withdrawal from another substance. | 0..1 | boolean | |
| SedaUnspecifiedSymptoms | null | 0..1 | group | |
| SedaUnspecifiedSymptoms.549 | 549. This category applies to presentations in which symptoms characteristic of an sedative, hypnotic, or anxiolytic-related disorder that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning predominate but do not meet the full criteria for any specific sedative, hypnotic, or anxiolytic-related disorder or any of the disorders in the substance-related and addictive disorders diagnostic class. | 0..1 | boolean | |
| meetsSedaIntoxCriteria | null | 0..1 | group | |
| meetsSedaIntoxCriteria.1 | Meets Criteria for Sedative, Hypnotic, or Anxiolytic Intoxication Diagnosis? | 0..1 | boolean | |
| sedspecifyparticularwithdraw | null | 0..1 | group | |
 sedspecifyparticularwithdraw.1 | Specify the particular Sedative, Hypnotic, or Anxiolytic | 0..1 | text | |
| sedspecifyparticularunspeci | null | 0..1 | group | |
| sedspecifyparticularunspeci.1 | Specify the particular Sedative, Hypnotic, or Anxiolytic | 0..1 | text | |
| Documentation for this format | ||||